Patient and Physician Exposure to Artificial Intelligence Hype

Research output: Contribution to journalReview articleContributedpeer-review

Contributors

  • Scott Monteith - , Michigan State University College of Human Medicine (MSUCHM) (Author)
  • Tasha Glenn - , ChronoRecord Association, Inc. (Author)
  • John R Geddes - , University of Oxford (Author)
  • Peter C Whybrow - , University of California at Los Angeles (Author)
  • Eric D Achtyes - , Western Michigan University Homer Stryker M.D. School of Medicine (WMed) (Author)
  • Rita Bauer - , Department of Psychiatry and Psychotherapy (Author)
  • Michael Bauer - , Department of Psychiatry and Psychotherapy (Author)

Abstract

Both patients and physicians are routinely exposed to the corporate promotion of artificial intelligence (AI) for healthcare products. Hype for AI products may impact both patient behavior and attitudes about healthcare. Corporate AI hype may intentionally overlook the known limitations associated with AI products and focus solely on potential benefits. As AI is increasingly integrated into medicine, physicians are also routinely subject to AI hype. As the promotion and use of AI products have grown dramatically in recent years, physicians should be aware of the potential benefits and risks of AI products despite the hype.

Details

Original languageEnglish
Pages (from-to)126-128
Number of pages3
JournalPharmacopsychiatry
Volume59
Issue number3
Early online date12 May 2025
Publication statusPublished - May 2026
Peer-reviewedYes

External IDs

Scopus 105005159868
ORCID /0000-0002-2666-859X/work/204618390

Keywords

Keywords

  • AI hype, hype, medical hype, artificial intelligence